INSIGHTS ON CLINICAL TRIAL DESIGN
-
How To Make Your Clinical Trial Protocol More IRT/RTSM Friendly?
Simplifying and standardizing protocol elements strengthens RTSM builds by creating clear, repeatable structures that cut risk and boost reliability across the study lifecycle.
-
Why Early Phase Speed Depends On Oncology Expertise
Early phase oncology speed depends on confident, oncology‑specific decisions made upfront. Learn why scientific expertise, realistic planning, and foresight determine whether programs maintain momentum.
-
Pharma R&D Annual Review Supplement: New Active Substances
Last year was by some distance the best year ever in terms of new active substances. Explore the 105 new debuts that easily outstrips that of the previous record holder, 2021’s, 97.
-
Why Ophthalmology Assessments Are Non-Negotiable
Learn about the challenges researchers face when incorporating ophthalmology assessments into clinical trials, and how you can address those obstacles to the benefit of your trial and its participants.
-
How AI Is Reshaping Trial Design, Execution, And Disclosure9/25/2025
AI has quietly embedded itself into the operational heart of clinical development, where it is accelerating decisions, reducing manual burden, and improving outcomes.
-
How High-Performing Trials Operationalize Health Equity Early9/17/2025
Explore how embedding inclusion early in clinical development enhances enrollment, strengthens data integrity, and improves outcomes, especially in oncology and rare disease trials.
-
A New Blueprint For Transforming Feasibility And Recruitment9/22/2025
Discover how a connected approach links feasibility and recruitment, using real-world data to design realistic protocols, reach the right patients, and accelerate enrollment with confidence.
-
On The GO: Inside The World Of Clinical Trial Travel Coordination (USA)11/19/2024
Clinical trial Concierge Coordinators provide personalized support, addressing travel, logistics, and unique challenges for participants and caregivers, ensuring engagement, and trial success.
-
Combination Therapy Dose Optimization In Oncology Trials3/30/2026
Optimize dose selection in oncology trials by moving beyond toxicity limits. Use advanced modeling and benefit-risk analysis to improve efficacy and meet modern regulatory standards.
CLINICAL TRIAL DESIGN SOLUTIONS
-
A new collaboration helps to remove obstacles from the critical path, reduce development risks, eliminate the white space in pre-clinical drug development, and shorten the pathway to clinical development.
-
When considering clinical trial disclosure solutions, it is important to understand the potential partner’s practical experience and how their solution fits your compliance needs today and in the future.
-
Achieve unprecedented control over the study creation and deployment process with a no-code interface.
-
Simplify biosafety oversight and accelerate study startup with expert guidance that ensures NIH compliance while protecting researchers, communities, and the environment.
-
Our network of 150+ active clinical trial sites allows us to identify potential partners that align with your therapeutic area, geographic preference, and specialty population requirements.